The Regulation of Body Weight | ContinuingEducation.com

$20.00

i 1.00 Hours

Course Overview

This continuing education course aims to develop pharmacists’ knowledge of obesity and weight management treatment options. Learners will be exposed to a brief disease state background, including definitions, classification, and measurements of obesity. Then treatment options based on three of the most current obesity guidelines will be reviewed, including nonpharmacologic treatments, pharmacologic treatments, and bariatric surgery. The focus will be placed on drug treatments and other pharmacotherapy implications.

About the Course Author

Nathan Jakowski, PharmD, is a clinical pharmacist for an integrated delivery network. He specializes in managed care, specifically clinical programs and formulary management. His prior experience includes inpatient and ambulatory care settings.

Nathan Jakowski Pharm D has declared that no conflict of interest, Relevant Financial Relationship or Relevant Non-Financial Relationship exists.

Get started now and your first course is free!

CE-PRO Membership

Become a member today and enjoy instant savings on all courses

$19.95 / year

CE-PRO is a membership program that gives you 50% OFF everything you buy and much more.

CE-PRO Membership Benefits

50% Discount on All Course Purchases

Free CE Alerts

Detailed Transcripts

License Tracking/Reminders

GET CE-PRO

Accreditation Information

Certificates provided by accrediting body (1 Match)

Accreditation Council for Pharmacy Education

1.00HOURS

In support of improving patient care, Relias LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Type Activity: Knowledge
Target Audience Designation: P
ACPE Universal Activity Number: JA4008266-0000-21-055-H04-P

Course Details

Course Code:

REL-ACU-0-PHARM55
Hours:

1.00
Type:

Online Course
Release Date:

2019-08-01
Expiration Date:

2022-06-26
Learning Objectives:

Define obesity and review measurements and classifications.; Describe nonpharmacologic treatment for obesity.; Discuss bariatric surgery and pharmacotherapy implications.; Review the seven drugs approved by the U.S. Food and Drug Administration (FDA) as pharmacologic agents for weight loss.
Target Audience:

The target audience for this course is: Pharmacists; in the following settings: Acute Care Facility.
Course Delivery Method and Format:

Asynchronous/Online Distance Learning; please see certificate details for specifics on delivery format.
Relias has a grievance policy in place to facilitate reports of dissatisfaction. Relias will make every effort to resolve each grievance in a mutually satisfactory manner. In order to report a complaint or grievance please contact Relias.
If you require special accommodations to complete this module, please contact Relias Support by completing the web form (https://www.relias.com/help) or by using the chat functionality.
All courses offered by Relias, LLC are developed from a foundation of diversity, inclusiveness, and a multicultural perspective. Knowledge, values and awareness related to cultural competency are infused throughout the course content.
Reference herein to any specific commercial product, process, or service by trade name, trademark, service mark, manufacturer or otherwise does not constitute or imply any endorsement, recommendation, or favoring of, or affiliation with, Relias, LLC.
All characteristics and organizations referenced in the following training are fictional. Any resemblance to any actual organizations or persons living or dead, is purely coincidental.
To earn continuing education credit for this course you must achieve a passing score of 80% on the post-test and complete the course evaluation.
Accommodations:

If you require special accommodations to complete this module, please contact Relias Customer Support here.
Disclosures:

Expert Reviewers, Instructors, and Staff Writers disclosures will be listed above after the individuals' biographical paragraph. All other members involved within the planning of this educational activity have declared no conflict of interest exists when planning and developing this course.